InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.63
(
0.00%
)
US TECH 100
19,204.00
(
-0.06%
)
Dow Jones
39,204.68
(
0.20%
)
Brent Oil
84.80
(
0.38%
)
Bitcoin
61,723.78
(
1.50%
)
Post# of 345995
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

nuke661

Send PM Follow Ignore
Followers 8
Posts 389
Boards Moderated 0
Alias Born 02/12/2009

nuke661

Re: None

Monday, 08/31/2009 9:23:48 AM

Monday, August 31, 2009 9:23:48 AM

Post# of 345995
The acquisition of a doctor with Dr. Chabner's history and significant standing in the US oncology profession along with his influence in cancer policies - as implied in the release article info - seems to me to be a solid indicator of Bavituximab making a big step into the US cancer mainstream.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!